|
RARS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36540001527408E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.53690418567021E-11 |
| Normal-vs-Stage2 |
3.619900E-03 |
| Normal-vs-Stage3 |
2.029900E-04 |
| Normal-vs-Stage4 |
3.68440000000358E-05 |
| Stage1-vs-Stage2 |
5.676600E-01 |
| Stage1-vs-Stage3 |
5.972300E-02 |
| Stage1-vs-Stage4 |
5.927000E-01 |
| Stage2-vs-Stage3 |
5.733800E-01 |
| Stage2-vs-Stage4 |
8.647400E-01 |
| Stage3-vs-Stage4 |
3.343800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62110325163667E-11 |
| Normal-vs-AfricanAmerican |
2.548200E-01 |
| Normal-vs-Asian |
2.614000E-01 |
| Caucasian-vs-AfricanAmerican |
2.3778999999946E-05 |
| Caucasian-vs-Asian |
3.556200E-01 |
| AfricanAmerican-vs-Asian |
6.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.4628999667774E-10 |
| Normal-vs-Female |
2.24560000039453E-07 |
| Male-vs-Female |
4.976800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.587800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.32260002739093E-09 |
| Normal-vs-Age(61-80Yrs) |
5.73650005275539E-09 |
| Normal-vs-Age(81-100Yrs) |
2.694300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.170600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.326000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.680800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.010200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.928800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.512600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.944200E-02 |
| Normal-vs-Grade 2 |
1.6569967620228E-11 |
| Normal-vs-Grade 3 |
8.95620000385122E-08 |
| Normal-vs-Grade 4 |
1.428230E-02 |
| Grade 1-vs-Grade 2 |
6.048400E-01 |
| Grade 1-vs-Grade 3 |
9.817200E-01 |
| Grade 1-vs-Grade 4 |
5.170400E-01 |
| Grade 2-vs-Grade 3 |
1.174810E-01 |
| Grade 2-vs-Grade 4 |
1.412230E-02 |
| Grade 3-vs-Grade 4 |
1.703360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.1094237467878E-15 |
| Normal-vs-ccB subtype |
1.382090E-03 |
| ccA subtype-vs-ccB subtype |
3.36199999950715E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31190003305193E-09 |
| Normal-vs-N1 |
2.459600E-01 |
| N0-vs-N1 |
3.333000E-01 |
|
|
